Susquehanna lowered the firm’s price target on Endava (DAVA) to $50 from $55. The firm noted the company’s CEO on the earnings call discussed leveraging their AI-enabled capabilities like Morpheus and Compass to accelerate client transformations and a solid pipeline, however he cautioned these large scale projects require business case validation and prolonged ideation.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DAVA:
- Endava Reports Q2 FY2025 Results and Share Buyback
- Endava: Despite Mixed Results, Strong US Market and Strategic Initiatives Reinforce Buy Rating
- Endava plc to Hold General Meeting to Approve $100 Million Share Repurchase Program
- Endava announces $100M share repurchase program
- Endava Announces Q2 Fiscal 2025 Results and $100 Million Share Repurchase Program
